IASON GmbH

Our vision is to enhance our global leadership position and grow with our customers as their preferred and trusted partner. Our products Efdege®, IASOcholine®, IASOflu®, IASOdopa® and IASOglio® are mainly used for PET, a technique used for producing high-resolution images of cancer, but application today also extends to a growing number of non-oncological indications, e.g. We develop, manufacture and distribute radiopharmaceutical products that meet industry-leading standards in quality, efficacy and innovation. We are wholly dedicated to the nuclear medicine industry, working closely with our clinicians and suppliers to stay ahead of trends and deliver effective radiopharmaceutical solutions. We are striving to improve the quality of care and health outcomes through diagnostics and treatment. We will achieve this by delivering top quality products, ensuring 100% reliable service, offering a larger product portfolio and newer solutions. For patients:To provide the necessary nuclear diagnostics and therapy that allow for better lives every day.For customers: To act as a trusted end-to-end solution provider, delivering high-quality products, unrivaled reliability and superior service. To provide the necessary nuclear diagnostics and therapy that allow for better lives every day.